Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mac-Chem Products (India) is a specialized pharmaceutical company focused on the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company is particularly recognized for its expertise in cytotoxic (oncology) products, operating a state-of-the-art manufacturing facility in Boisar, Maharashtra. In 2022, Zydus Lifesciences acquired a 50% stake in the company to bolster its oncology portfolio and API supply chain. Mac-Chem serves both domestic and international markets, providing high-quality chemical entities for various therapeutic segments including cardiovascular and central nervous system disorders. The company's facilities are compliant with international regulatory standards, including WHO-GMP.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mac-Chem Products India.